Begin with a defined patient need.
“Add an ambulatory care pharmacist” is not yet a service plan. Name the population, current gap and care outcome the organization is trying to improve. The answer might involve uncontrolled chronic disease, medication access, transitions after discharge, high-risk regimens, avoidable utilization, fragmented follow-up or a specialty-clinic capacity constraint.
Use local evidence where possible. Referral backlogs, quality measures, readmissions, medication-related incidents, appointment availability, patient access data and clinician workload can establish a baseline. The purpose is not to prove that a pharmacist alone will solve every issue. It is to identify the work that pharmacy is appropriately positioned to own or support.
Write a one-page service charter
- Target population and inclusion or referral criteria
- Medication-related problem the service will address
- Initial scope and explicit exclusions
- Care setting, visit channels and operating hours
- Clinical and operational stakeholders
- Expected outputs and intended outcomes
- Launch assumptions, constraints and review date
ASHP's ambulatory care guidance places leadership, patient care, medication distribution and the necessary facilities and resources within the service model. That breadth is useful: a clinic is not ready simply because a qualified pharmacist has accepted an offer.
Establish authority and governance.
Map each proposed activity to the applicable jurisdiction, organizational policy and credentialing route. Collaborative practice arrangements, prescriptive authority, ordering of tests, immunization, documentation and reimbursement conditions vary. Interstate or remote service models can add further licensure and operational requirements.
What may the pharmacist assess, recommend, initiate, modify, monitor, document or escalate?
Which license, training, board certification and organization-specific competence evidence are required?
Who approves protocols, owns quality review, handles incidents and maintains the service?
Which findings require physician, specialist, emergency or operational escalation, and how quickly?
Do not copy a collaborative practice agreement from another state or institution and assume it transfers. Involve pharmacy leadership, medical leadership, compliance, legal counsel, credentialing, information security, revenue integrity and affected clinic teams at the appropriate stage.
Design a team around the work.
Translate the service charter into tasks, then decide which work requires pharmacist judgment and which work can be supported by trained technicians, coordinators, analysts or shared services under applicable rules and policy. This usually produces a more resilient model than assigning clinical care, access work, scheduling, data collection and every administrative dependency to one pharmacist.
Patient assessment, medication-related decisions within authority, care planning, documentation and clinical escalation.
Permitted technical, access, preparation, coordination or data tasks with defined training and supervision.
Referral intake, scheduling, room or virtual workflow, communication and continuity arrangements.
Measure definitions, reporting, payer review, coding support and business-case monitoring.
Set a credential standard proportional to the work. BCACP is a relevant specialty certification for ambulatory care, but requiring it for every role may exclude candidates whose verified experience and other credentials meet the need. Conversely, calling it preferred when the organization will require it for privileging can waste time. State whether residency or certification is required at start, accepted through an alternative pathway or supported after hire.
Build leave, vacancy and surge coverage before launch. If the service stops whenever one person is absent, the organization has created a single point of failure rather than dependable access.
Build the clinical and digital workflow.
Follow a patient through the proposed service from identification to closure. Determine who can refer, how eligibility is confirmed, what information is available before the visit, how consent and communication are handled, where the care plan is documented, how orders or recommendations move, and how follow-up is scheduled.
Operational readiness questions
- Can the pharmacist see the medication, diagnosis, laboratory and encounter information needed?
- Is documentation visible to the clinicians expected to act on it?
- Are referral criteria clear enough to produce an appropriate panel?
- Is there a defined route for urgent findings and missed follow-up?
- Who owns prior authorization, medication access and patient outreach tasks?
- How are live video, telephone or remote monitoring encounters governed where used?
- What happens during downtime, leave, demand spikes or clinic closure?
Test the workflow with real scenarios before full launch. Include a routine follow-up, an incomplete referral, an urgent result, a patient who cannot be reached, a technology failure and a coverage gap. A tabletop exercise often reveals role ambiguity that a process diagram misses.
Measure sustainable value without overpromising.
Use a balanced scorecard that reflects the service charter. Clinical outcomes matter, but so do access, safety, patient experience, clinician capacity, utilization, reliability and cost. Define the baseline, denominator, data source, owner and review cadence for every measure.
Disease-state or medication outcomes that the service can reasonably influence.
Referral completion, time to appointment, follow-up and medication-access resolution.
Medication issues identified, resolved or escalated using a defined methodology.
Patient and care-team feedback interpreted alongside response and participation rates.
Relevant care use measured with appropriate attribution and comparison limits.
Documented revenue, avoided cost or capacity impact, with assumptions shown and validated.
Do not assume that a pharmacist can bill every service directly. ASHP's July 2025 billing reference describes several codes and arrangements while noting limits, payer differences and state-specific conditions. Revenue integrity and legal teams should validate the current pathway. A service may also create value through quality performance, access, care-team capacity or avoided utilization, but those claims need a defensible method.
Set stage gates. A pilot can test demand, workflow and measure quality before scale. Expansion should follow evidence and operational readiness, not only enthusiasm or a single promising month.
Recruit and onboard against a service scorecard.
Turn the service design into a role brief. Include reporting relationships, patient population, practice authority, schedule, panel or demand assumptions, team support, license needs, required and preferred credentials, first-year priorities and how success will be assessed.
Evaluate evidence consistently
- Longitudinal patient-care judgment relevant to the target population
- Practice within collaborative or protocol-led environments where applicable
- Clear, interoperable clinical documentation
- Communication across professions and levels of seniority
- Use of quality measures and honest interpretation of outcomes
- Service development, change management or workflow improvement
- Teaching, precepting or team development where the role requires it
Onboarding should complete the operating model, not restart its design. Use a phased plan for access, training, competence assessment, supervised practice, protocol authorization, panel growth and outcome review. Agree who decides when each phase is complete.
Verovian can help translate the service scope into a disciplined US search brief, evidence scorecard and consent-led candidate process.
Brief an ambulatory care search Talk to the US pharmacy desk
Ambulatory service FAQ.
Should every ambulatory care pharmacist role require BCACP certification?
No. Set the requirement from the service scope, patient risk, credentialing standard and available talent market. BCACP may be required, preferred or supported after hire, but the decision should be explicit and applied consistently.
Can an ambulatory care pharmacist bill Medicare directly?
Do not assume direct Medicare billing. ASHP's current billing reference describes multiple arrangements and limitations, including services furnished under eligible billing providers. Confirm current federal, state, payer and organizational rules for the planned model.
What should an ambulatory pharmacy service measure?
Use a balanced set of clinical, access, safety, experience, utilization, operational and financial measures tied to the population and service promise. Define each measure, owner, baseline and review cadence before launch.
When should recruitment begin?
Begin after the organization has defined the initial scope, authority, reporting line, credential standard, support model, schedule, success measures and realistic start conditions. Those decisions make the role recruitable and reduce avoidable mismatch.
Primary sources used.
- ASHP Guidelines: Minimum Standard for Ambulatory Care Pharmacy Practice
- ASHP, Compensation and Sustainable Business Models
- ASHP, Pharmacist Billing and Coding for Patient Care Clinical Services, July 2025
- ASHP, Initiating or Expanding Population Health Management Services, July 2025
- ASHP, Value Based Payment Models FAQ, July 2025
- Board of Pharmacy Specialties, BCACP Examination Specifications effective October 2025
Reviewed July 26, 2026. This briefing supports workforce planning. It is not legal, regulatory or clinical advice. Confirm current requirements and financial assumptions with the relevant board of pharmacy, regulators, payers, credentialing body, revenue-integrity team, legal adviser and employer policies.